secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0001628280-23-022935
Event type: litigation
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland settles breach-of-contract suit with Melinta/Targanta, receives undisclosed consideration
--------------------------------------------------------------------------------

- Settlement finalized June 16, 2023; case closed in NY Supreme Court.
- Company had sought $1M in milestone payments for NDA/sNDA filings.
- Defendants obtained license to Company patents for product development.
- Original action filed Feb 2022; refiled Nov 2022 after jurisdiction change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828023022935/0001628280-23-022935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828023022935/cpix-20230616.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-022935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer